COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 2464: Articles 24631-24640  | Next

Towards the design of multiepitope-based peptide vaccine candidate against SARS-CoV-2
Hasanain Abdulhameed Odhar, Salam Waheed Ahjel, Suhad Sami Humadi
10.1101/2020.07.07.186122 — Posted: 2020-07-08
Genes associated with liver damage signalling pathways may impact the severity of COVID-19 symptoms in Spanish and Italian populations
Leire Moya, Samaneh Farashi, Prashanth N Suravajhala, Panchadsaram Janaththani, Jyotsna Batra
10.1101/2020.07.03.179028 — Posted: 2020-07-08 Discussion: Onsite
Reconstructing the global dynamics of under-ascertained COVID-19 cases and infections
Golding, N., Russell, T. W., Abbott, S., Hellewell, J., Pearson, C. A. B., van Zandvoort, K., Jarvis, C. I., Gibbs, H., Liu, Y., Eggo, R. M., Edmunds, J. W., Kucharski, A. J.
10.1101/2020.07.07.20148460 — Posted: 2020-07-08
Ranking the effectiveness of worldwide COVID-19 government interventions
Haug, N., Geyrhofer, L., Londei, A., Dervic, E., Desvars-Larrive, A., Loreto, V., Pinior, B., Thurner, S., Klimek, P.
10.1101/2020.07.06.20147199 — Posted: 2020-07-08
Modeling reductions in SARS-CoV-2 transmission and hospital burden achieved by prioritizing testing using a clinical prediction rule
Reimer, J. R., Ahmed, S. M., Brintz, B., Shah, R. U., Keegan, L. T., Ferrari, M. J., Leung, D. T.
10.1101/2020.07.07.20148510 — Posted: 2020-07-08
Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19
Dogan, M., Kozhaya, L., Placek, L., Gunter, C., Yigit, M., Hardy, R., Plassmeyer, M., Coatney, P., Lillard, K., Bukhari, Z., Kleinberg, M., Hayes, C., Arditi, M., Klapper, E., Merin, N., Liang, B. T., Gupta, R., Alpan, O., Unutmaz, D.
10.1101/2020.07.07.20148106 — Posted: 2020-07-08
Joint Detection of Serum IgM/IgG Antibody is An Important Key to Clinical Diagnosis of SARS-COV-2 Infection
Hu, F., Shang, X., Chen, M., Zhang, C.
10.1101/2020.07.07.20146902 — Posted: 2020-07-08
Epidemiology of SARS-CoV-2 Emergence Amidst Community-Acquired Respiratory Viruses
Leuzinger, K., Roloff, T., Gosert, R., Soegaard, K., Naegele, K., Rentsch, K., Bingisser, R., Nickel, C., Pargger, H., Bassetti, S., Bielicki, J. A., Khanna, N., Tschudin Sutter, S., Widmer, A., Hinic, V., Battegay, M., Egli, A., Hirsch, H. H.
10.1101/2020.07.07.20148163 — Posted: 2020-07-08
Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (Pilot Trial)
Gorial, F. I., Mashhadani, S., Sayaly, H. M., Dakhil, B. D., AlMashhadani, M. M., Aljabory, A. M., Abbas, , H. M., Ghanim, M., Rasheed, J. I.
10.1101/2020.07.07.20145979 — Posted: 2020-07-08 Discussion: Onsite
No evidence of viral polymorphisms associated with Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS).
Pang, J., Boshier, F. A. T., Alders, N., Dixon, G., Breuer, J.
10.1101/2020.07.07.20148213 — Posted: 2020-07-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).